Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
68Ga PSMA-HBED-CC PET in prostate cancer biochemical recurrence
NCT03389451Phase 3Completed
- Start
- Feb 2018
- Primary completion
- Jul 2019
- Modality
- Peptide-Drug Conjugates
- Countries
- 1
01
Overview
A Phase 3 trial of gallium ga-68 gozetotide in prostate cancer (PCa). Started Feb 2018; status: completed.
02
Drugs
gallium ga-68 gozetotide
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT03389451.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03389451.